Cisplatin and Hepatic cyst - a phase IV clinical study of FDA data

Summary:

Hepatic cyst is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Dexamethasone, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Hepatic cyst when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Hepatic cyst?

Hepatic cyst is found to be associated with 781 drugs and 649 conditions by eHealthMe. Check the latest studies of Hepatic cyst.

On Jul, 07, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 28 people (0.03%) have Hepatic cyst.

Among these 28 people:

How long have people been on Cisplatin when they have Hepatic cyst? *

What is the gender of people who have Hepatic cyst when taking Cisplatin? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Hepatic cyst when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

Dexamethasone: 12 people, 42.86%
Prednisone: 11 people, 39.29%
Cyclophosphamide: 11 people, 39.29%
Carmustine: 10 people, 35.71%
Gemcitabine: 10 people, 35.71%
Etoposide: 10 people, 35.71%
Vincristine Sulfate: 10 people, 35.71%
Cytarabine: 10 people, 35.71%
Melphalan: 10 people, 35.71%
Doxorubicin Hydrochloride: 9 people, 32.14%

What are other side effects people have besides Hepatic cyst? *

Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 11 people, 39.29%
Scar: 11 people, 39.29%
Pelvic Venous Thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins): 10 people, 35.71%
Urinary Retention (the inability to completely or partially empty the bladder): 10 people, 35.71%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 10 people, 35.71%
Blood Bilirubin Increased: 10 people, 35.71%
Glomerular Filtration Rate Decreased: 10 people, 35.71%
Disease Progression: 9 people, 32.14%
Gallstones (stone formation by bile component): 4 people, 14.29%
Pleural Effusion (water on the lungs): 4 people, 14.29%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 13 people, 46.43%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 7.14%
Breast Cancer Metastatic: 2 people, 7.14%
White Blood Cell Count Abnormal: 1 person, 3.57%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 3.57%
Metastases To Bone (cancer spreads to bone): 1 person, 3.57%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 3.57%
Gastroesophageal Cancer: 1 person, 3.57%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 3.57%
Bronchial Disorder: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Hepatic cyst?

- Check whether Hepatic cyst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Hepatic cyst treatments and more:

Hepatic cyst (5,071 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic cyst:

Hepatic cyst (781 drugs)

Browse all the conditions that are associated with Hepatic cyst:

Hepatic cyst (649 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.